TC
SRDX

TFS Capital’s Surmodics SRDX Stock Holding History

TFS Capital’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,221
Closed -$217K – 883
2016
Q3 		$217K Sell
7,221
-2,311
-24% -$63.5K 0.05% 526
2016
Q2 		$224K Buy
+9,532
New +$209K 0.04% 687
2015
Q2 		– Sell
-19,467
Closed -$507K – 1070
2015
Q1 		$507K Sell
19,467
-22,310
-53% -$531K 0.05% 548
2014
Q4 		$923K Buy
+41,777
New +$885K 0.09% 380
2014
Q1 		– Sell
-43,942
Closed -$1.07M – 1559
2013
Q4 		$1.07M Sell
43,942
-126,747
-74% -$2.99M 0.05% 527
2013
Q3 		$4.06M Sell
170,689
-27,403
-14% -$587K 0.19% 136
2013
Q2 		$3.96M Buy
+198,092
New +$4.96M 0.17% 143

Other funds holding SRDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TFS Capital's SRDX Position: Q4 2016 in Review

TFS Capital sold out of Surmodics (SRDX) in Q4 2016, closing a stake of 7,221 shares — an estimated $217K sold.

TFS Capital first reported a position in SRDX in Q2 2013 and held it in 7 quarters. The position peaked at $4.06M in Q3 2013. 116 funds tracked by Wall St. Rank hold SRDX as of Q4 2016.

  • TFS Capital reported no remaining Surmodics position as of Q4 2016 after selling out during the quarter.
  • TFS Capital sold 7,221 Surmodics shares in Q4 2016, an estimated $217K.
  • TFS Capital first reported a position in Surmodics in Q2 2013 and held it in 7 quarters.
  • TFS Capital's Surmodics position peaked at $4.06M in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Surmodics as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.